Acquired Expansion Recent acquisition by Flourishresearch and prior Florida expansion indicate ENCORE is in a growth phase with access to a broader network and resources, presenting selling opportunities for integrated CRO services, site network optimization, and cross-sell of trial management capabilities.

Florida Network Multi-location Florida presence with a community-based physician model suggests upsell potential for site-level consultancy, local regulatory support, patient recruitment services, and centralized CTMS optimization to improve trial timelines.

CTMS Advantage In-house Clinasyst Next Gen CTMS and a patient database exceeding 100,000 indicate opportunities to offer data analytics, patient sourcing, and trial matching services to sponsors seeking faster enrollment and real-world insights.

Trial Experience Extensive experience with over 2,500 Phase 1-4 trials across inpatient and outpatient settings demonstrates credibility for sponsors requiring diverse trial strategies, site feasibility assessments, and scalable trial execution support.

Medium Sized Small-to-mid sized enterprise with 11-50 employees sits between boutique and large CROs, creating a sales path for mid-market sponsorships, flexible engagement models, and personalized sponsor-site collaboration solutions.